ICICI Direct has initiated coverage on FMCG major Marico Limited with a BUY call, highlighting a 12-month target price of Rs 870 against a current market price of Rs 736, implying an upside potenti

ICICI Direct has refrained from issuing a traditional recommendation for the Corona Remedies initial public offering, designating it as "UNRATED" in their latest assessment.

Bengaluru-headquartered Aequs Limited enters the capital markets with a Rs 922 crore public offering priced between Rs 118-124 per share, seeking to capitalize on robust aerospace sector dynamics w

ICICI Securities has reiterated its BUY recommendation on Mahindra Lifespace Developers, setting a target price at Rs 550 per share with a 12-month horizon.

ICICI Securities has reaffirmed a BUY rating for Tata Steel, emphasizing the company’s poised recovery and capacity-driven growth, with a fresh target price of Rs 210 per share and a 12-month persp

ICICI Direct has recommended a BUY rating on Narayana Hrudayalaya (NARHRU), a leading chain of multi-specialty hospitals, with a target price of Rs 1,485, representing a potential upside of 22% fro